D. E. Shaw & Co., Inc. Nkarta, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $107 Billion
- Q3 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Nkarta, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 99,658 shares of NKTX stock, worth $252,134. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,658Holding current value
$252,134% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding NKTX
# of Institutions
129Shares Held
66.5MCall Options Held
173KPut Options Held
20K-
Ra Capital Management, L.P. Boston, MA10.8MShares$27.3 Million0.68% of portfolio
-
Commodore Capital LP New York, NY4.66MShares$11.8 Million1.79% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$10.3 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA4.03MShares$10.2 Million0.97% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$9.53 Million9.87% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $123M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...